SCHEMBL16359671

SCHEMBL16359671

O=C(NCCCn1ccnc1)c1ccc(I)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.78
NPC1 O15118 1/20 0.78
POLB P06746 1/20 0.75
ALDH1A1 P00352 2/20 0.70
MAPT P10636 1/20 0.70
TSHR P16473 1/20 0.70
HTT P42858 2/20 0.69
KDM4E B2RXH2 1/20 0.69
CYP19A1 P11511 1/20 0.67
MEN1 O00255 2/20 0.66
KMT2A Q03164 2/20 0.66
GAA P10253 1/20 0.66
MAPK1 P28482 2/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21098369 0.93 SMN1; SMN2 (0.89) SMN1; SMN2NPC1POLBALDH1A1MAPT
SCHEMBL4484066 0.88 SMN1; SMN2 (0.80) SMN1; SMN2NPC1POLBALDH1A1MAPT
SCHEMBL4770380 0.87 SMN1; SMN2 (0.78) SMN1; SMN2NPC1POLBALDH1A1MAPT
SCHEMBL13211944 0.87 SMN1; SMN2 (0.78) SMN1; SMN2NPC1POLBALDH1A1MAPT
SCHEMBL6571604 0.87 SMN1; SMN2 (0.84) SMN1; SMN2NPC1POLBALDH1A1MAPT
SCHEMBL95881 0.87 SMN1; SMN2 (0.78) SMN1; SMN2NPC1POLBALDH1A1MAPT
SCHEMBL5257694 0.87 SMN1; SMN2 (0.78) SMN1; SMN2NPC1POLBALDH1A1MAPT
SCHEMBL1775216 0.86 SMN1; SMN2 (0.82) SMN1; SMN2NPC1POLBALDH1A1MAPT
SCHEMBL13762099 0.85 MEN1 (0.78) SMN1; SMN2NPC1POLBALDH1A1MAPT
SCHEMBL13766445 0.85 SMN1; SMN2 (0.74) SMN1; SMN2NPC1POLBALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008127715-A1 CARBOLINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISEASES PTC THERAPEUTICS, INC. (US) 2008-10-23 WO disclosed